The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the launch of a pioneering Artificial Intelligence (AI) Sandbox, a first-of-its-kind regulatory initiative designed to support the safe adoption of AI in medicines development and strengthen drug safety monitoring across the healthcare sector. The programme will
AnaTel™ helps medical device and SaMD companies accelerate software development, generate regulatory grade documentation, and reduce development cycle times by up to 60% Tata Elxsi, a global leader in design and technology services, today announced the launch of AnaTel™, an AI-native software development platform for healthcare
Granules Life Sciences Receives VAI Classification following US FDA Inspection Granules India Limited today announced that its wholly owned subsidiary, Granules Life Sciences Private Limited (GLS), has concluded a recent US FDA inspection of its manufacturing facility at Shamirpet, Telangana, with an inspection classification of Voluntary Action Indicated
Tata Elxsi, a global leader in design and technology services, and Terumo Corporation, a global medical innovation company, today inaugurated the 'Terumo–Tata Elxsi Offshore Development Center'. This dedicated center will support the development of Terumo's cardiac and vascular solutions, strengthening engineering and innovation capabilities while
A newly published clinical study has reported that autologous umbilical cord blood infusion using a child own’s stored core blood is very safe for young children who are diagnosed with autism spectrum disorder (ASD), and may be associated with overall improvements in a subset of
Granules India Limited today announced that its wholly owned subsidiary, Granules Life Sciences Private Limited (GLS), located in Hyderabad (FEI: 3030495702), has received U.S. Food and Drug Administration (FDA) approval for a product that was the subject of a Pre- Approval Inspection (PAI) conducted between
Union Health Minister J.P. Nadda has highlighted the remarkable transformation of India’s healthcare landscape, noting that the country has expanded from a single All India Institute of Medical Sciences (AIIMS) in New Delhi to 23 AIIMS across the nation, symbolizing a new era of accessible
Partnerships with leading healthcare enterprises expand UST’s role in transforming the healthcare landscape at scale UST, a leading AI and technology transformation solutions company, has entered into a series of engagements with three prominent healthcare companies valued at over $2 billion, reaffirming its position as a
Healthium Medtech and the Centre for Cellular and Molecular Platforms (C-CAMP) recently launched the first cohort of the C-CAMP Healthium Innovations Program for Surgical Interventions and Medical Technologies in Bengaluru. This program is a part of the CSR initiative of Healthium Medtech. The partnership aims to
Indegene, a digital-first life sciences commercialization company, today announced the launch of a new center in London. This aligns with the company’s long-term growth strategy in Europe, reiterating its commitment to enable life sciences clients in the region to be future-ready. Indegene’s Europe-based clients can now
